| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,038,234 | 1,039,469 | 932,435 | 790,672 | | Cost of Revenue | 1,002,690 | 770,265 | 755,302 | 555,969 | | | Gross Profit | 35,544 | 269,204 | 177,133 | 234,703 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (2,466) | 237,769 | 146,221 | 200,590 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,010 | 31,435 | 30,912 | 34,113 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,750 | 4,418 | 3,613 | 6,194 | | Earnings Before Interest And Taxes | 41,760 | 35,853 | 34,525 | 40,307 | | Interest Expense | 4,064 | 4,160 | 3,986 | 4,237 | | Income Before Tax | 37,696 | 31,693 | 30,539 | 36,070 | | Income Tax Expense | 12,426 | 11,789 | 10,845 | 13,726 | | Minority Interest | (2,518) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,752 | 19,904 | 19,694 | 22,344 | | | Non-recurring Events | | Discontinued Operations | (1,460) | (485) | (449) | (921) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,292 | 19,419 | 19,245 | 21,423 | | Preferred Stock And Other Adjustments | (24) | 811 | (787) |
-
| | | Net Income Applicable To Common Shares | $21,268 | $20,230 | $18,458 | $21,423 |
|
0.51% Nasdaq 
Income Statement
